Ozempic® (semaglutide) — Novo Nordisk

The most prescribed GLP-1 in the U.S. Indicated for type 2 diabetes management with meaningful weight reduction in clinical studies. Sourced directly from Novo Nordisk, manufactured in Denmark and France, through Colombia's tier-one regulated pharmacy network. Not compounded. The original product.

Available in starter treatment plan doses only (0.25 mg / 0.5 mg).

Prescription required. Clinical evaluation available.